BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
22.35
-1.37 (-5.78%)
At close: Nov 18, 2024, 4:00 PM
22.44
+0.09 (0.40%)
After-hours: Nov 18, 2024, 5:01 PM EST
BridgeBio Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -438.86 | -643.2 | -481.18 | -562.54 | -448.72 | -260.59 | Upgrade
|
| Depreciation & Amortization | 6.29 | 6.49 | 6.77 | 5.84 | 1.46 | 0.86 | Upgrade
|
| Loss (Gain) From Sale of Assets | -178.32 | 1.24 | 6.26 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 12.72 | - | 4.73 | 3.56 | Upgrade
|
| Loss (Gain) From Sale of Investments | -29.4 | -18.31 | 8.22 | -29.91 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 14.49 | - | - | - | - | 20.87 | Upgrade
|
| Stock-Based Compensation | 102.7 | 108.71 | 91.56 | 99.51 | 58.46 | 21.37 | Upgrade
|
| Other Operating Activities | 31.81 | 12.29 | -91.92 | -6.43 | -30.57 | -28.75 | Upgrade
|
| Change in Accounts Receivable | 4.69 | 15.33 | 15.17 | -19.75 | - | -2.85 | Upgrade
|
| Change in Accounts Payable | 11.44 | 2.78 | -0.35 | 2.83 | -0.74 | -4.66 | Upgrade
|
| Change in Unearned Revenue | 19.6 | -5.44 | 15.26 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 5.34 | -7.61 | -2 | 12.52 | 15.67 | -3.41 | Upgrade
|
| Operating Cash Flow | -450.22 | -527.72 | -419.49 | -497.93 | -399.71 | -253.59 | Upgrade
|
| Capital Expenditures | -1.32 | -1.31 | -4.82 | -13.25 | -7.52 | -2.64 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 10 | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | 13.65 | - | - | Upgrade
|
| Divestitures | -0.14 | -0.5 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -4.79 | - | -1.5 | -35 | - | - | Upgrade
|
| Investment in Securities | 44.52 | 55.84 | 339.47 | -166.23 | -38.72 | -212.9 | Upgrade
|
| Other Investing Activities | 25.68 | - | 110 | - | -6.76 | -1.72 | Upgrade
|
| Investing Cash Flow | 63.95 | 54.03 | 453.15 | -200.83 | -52.99 | -217.25 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 1,204 | 550 | 36.94 | Upgrade
|
| Long-Term Debt Repaid | - | - | -20.49 | -124.12 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -23.42 | - | -20.49 | 1,080 | 550 | 36.94 | Upgrade
|
| Issuance of Common Stock | 320.38 | 459.22 | 8.08 | 20.46 | 14.13 | 368.95 | Upgrade
|
| Repurchase of Common Stock | -8.68 | -6.88 | -1.56 | -204.75 | -75.71 | - | Upgrade
|
| Other Financing Activities | -18.29 | -0.8 | 0.84 | -158.95 | -41.23 | -7.09 | Upgrade
|
| Financing Cash Flow | 270 | 451.54 | -13.13 | 736.45 | 447.19 | 398.79 | Upgrade
|
| Net Cash Flow | -116.26 | -22.15 | 20.52 | 37.69 | -5.52 | -72.05 | Upgrade
|
| Free Cash Flow | -451.54 | -529.03 | -424.32 | -511.18 | -407.23 | -256.23 | Upgrade
|
| Free Cash Flow Margin | -207.35% | -5686.62% | -546.46% | -733.23% | -4936.74% | -631.72% | Upgrade
|
| Free Cash Flow Per Share | -2.48 | -3.25 | -2.88 | -3.54 | -3.45 | -2.44 | Upgrade
|
| Cash Interest Paid | 88.52 | 61.11 | 54.44 | 29.77 | 15.32 | 6.09 | Upgrade
|
| Levered Free Cash Flow | -365.12 | -249.07 | -285.88 | -301.13 | -250.16 | -137.97 | Upgrade
|
| Unlevered Free Cash Flow | -309.03 | -198.26 | -235.61 | -271.89 | -227.25 | -132.49 | Upgrade
|
| Change in Net Working Capital | 101.16 | -56.19 | 37.11 | -23.27 | -16.91 | -14.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.